Stocks open mixed as investors eye signs of vaccine progress

/ / News

U.S. stocks opened near break-even levels on Wednesday amid signs of progress by vaccine-makers in developing a viable weapon against the COVID-19 pandemic’s unchecked spread. The S&P 500 was down a point to 3,608. The Dow Jones Industrial Average advanced 46 points, or 0.2%, to 29,830. The Nasdaq Composite fell 0.1% to 11,887. Equities have mostly traded sideways this week as investors continued to watch the trajectory of the coronavirus in the U.S. Pfizer Inc. said the vaccine candidate it has developed with BioNTech SE was 95% effective in an analysis of clinical trial data. Pfizer said it plans to seek authorization for the vaccine in the next few days.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.